FSCN1 and carcinoma: Understanding the mechanisms of FSCN1 transcriptional regulation in human carcinoma cells is an important question because it may lead to novel prognostic tools for early identification of the most biologically aggressive carcinomas, and/or potential novel therapeutic strategies to reduce tumour metastasis through inhibition of fascin expression.